Inhibitory function of NKT cells during early induction phase of nickel allergy

Immunobiology

Volumn 221, Issue 7, 2016, Pages 833-838

  Okuno, Hironori ^a   Satoh, Masashi ^a   Takeuchi, Emiko ^a   Eshima, Koji ^a   Terashima, Masazumi ^b   Komotori, Jun ^c   Habu, Sonoko ^d   Tamauchi, Hidekazu ^a,e   Iwabuchi, Kazuya ^a  

^a KITASATO UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

^c KEIO UNIVERSITY   (Japan)

^d JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e EHIME PREFECTURAL UNIVERSITY OF HEALTH SCIENCES   (Japan)

Author keywords

CD1d; Nickel allergy; NKT cells; GalCer

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; GAMMA INTERFERON; INTERLEUKIN 4; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR GATA 3; ALLERGEN; ALPHA-GALACTOSYLCERAMIDE; CD1D ANTIGEN; CYTOKINE; GALACTOSYLCERAMIDE; GATA3 PROTEIN, MOUSE; NICKEL;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DERMATITIS; EAR DISEASE; EAR SWELLING; FEMALE; IMMUNE RESPONSE; IMMUNOREACTIVITY; IMMUNOSUPPRESSIVE TREATMENT; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; MALE; MOUSE; NATURAL KILLER T CELL; NICKEL HYPERSENSITIVITY; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TH2 CELL; ANIMAL; BLOOD; C57BL MOUSE; CONTACT DERMATITIS; DELAYED HYPERSENSITIVITY; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; SKIN; TRANSGENIC MOUSE;

ALLERGENS; ANIMALS; ANTIGENS, CD1D; CYTOKINES; DERMATITIS, CONTACT; FEMALE; GALACTOSYLCERAMIDES; GATA3 TRANSCRIPTION FACTOR; HYPERSENSITIVITY, DELAYED; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; NATURAL KILLER T-CELLS; NICKEL; SKIN;

EID: 84956957992     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2016.01.012     Document Type: Article

References (38)

1. Adachi Y., Koseki H., Zijlstra M., Taniguchi M. Positive selection of invariant V alpha 14+ T cells by non-major histocompatibility complex-encoded class I-like molecules expressed on bone marrow-derived cells. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:1200-1204.
2. Andoh Y., Ogura H., Satoh M., Shimano K., Okuno H., Fujii S., Ishimori N., Eshima K., Tamauchi H., Otani T., Nakai Y., Van Kaer L., Tsutsui H., Onoé K., Iwabuchi K. Natural killer T cells are required for lipopolysaccharide-mediated enhancement of atherosclerosis in apolipoprotein E-deficient mice. Immunobiology 2013, 18:561-569.
3. - single-positive thymocyte subpopulation that expresses a highly skewed T-cell antigen receptor V beta family. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:6506-6510.
4. Behar S.M., Podrebarac T.A., Roy C.J., Wang C.R., Brenner M.B. Diverse TCRs recognize murine CD1. J. Immunol. 1999, 162:161-167.
5. Brossay L., Jullien D., Cardell S., Sydora B.C., Burdin N., Modlin R.L., Kronenberg M. Mouse CD1 is mainly expressed on hemopoietic-derived cells. J. Immunol. 1997, 159:1216-1224.
6. Brossay L., Chioda M., Burdin N., Koezuka Y., Casorati G., Dellabona P., Kronenberg M. CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J. Exp. Med. 1998, 188:1521-1528.
7. Calabi F., Jarvis J.M., Martin L., Milstein C. Two classes of CD1 genes. Eur. J. Immunol. 1989, 19:285-292.
8. Cen O., Ueda A., Guzman L., Jain J., Bassiri H., Nichols K.E., Stein P.L. The adaptor molecule signaling lymphocytic activation molecule-associated protein (SAP) regulates IFN-gamma and IL-4 production in V alpha 14 transgenic NKT cells via effects on GATA-3 and T-bet expression. J Immunol. 2009, 182:1370-1378.
9. Chen Y.H., Chiu N.M., Mandal M., Wang N., Wang C.R. Impaired NK1+ T cell development and early IL-4 production in CD1-deficient mice. Immunity 1997, 6:459-467.
10. de la Salle H., Mariotti S., Angenieux C., Gilleron M., Garcia-Alles L.F., Malm D., Berg T., Paoletti S., Maître B., Mourey L., Salamero J., Cazenave J.P., Hanau D., Mori L., Puzo G., De Libero G. Assistance of microbial glycolipid antigen processing by CD1e. Science 2005, 310:1321-1324.
11. Eguchi T., Kumagai K., Kobayashi H., Shigematsu H., Kitaura K., Suzuki S., Horikawa T., Hamada Y., Ogasawara K., Suzuki R. Accumulation of invariant NKT cells into inflamed skin in a novel murine model of nickel allergy. Cell Immunol. 2013, 284:163-171.
12. Gapin L., Matsuda J.L., Surh C.D., Kronenberg M. NKT cells derive from double-positive thymocytes that are positively selected by CD1d. Nat. Immunol. 2001, 2:971-978.
13. Godfrey D.I., MacDonald H.R., Kronenberg M., Smyth M.J., VanKaer L. NKT cells: what's in a name?. Nat. Rev. Immunol. 2004, 4:231-237.
14. Gumperz J.E., Miyake S., Yamamura T., Brenner M.B. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tet-ramer staining. J. Exp. Med. 2002, 195:625-636.
15. Hammond K.J., Pelikan S.B., Crowe N.Y., Randle-Barrett E., Nakayama T., Taniguchi M., Smyth M.J., van Driel I.R., Scollay R., Baxter A.G., Godfrey D.I. NKT cells are phenotypically and functionally diverse. Eur. J. Immunol. 1999, 29:3768-3781.
16. Hammond K.J., Pellicci D.G., Poulton L.D., Naidenko O.V., Scalzo A.A., Baxter A.G., Godfrey D.I. CD1d-restricted NKT cells: an interstrain comparison. J. Immunol. 2001, 167:1164-1173.
17. Harada M., Seino K., Wako H., Sakata S., Ishizuka Y., Ito T., Kojo S., Nakayama T., Tanibuchi M. Down-regulation of the invariant Valpha14 antigen receptor in NKT cells upon activation. Int. Immunol. 2004, 16:241-247.
18. Ise W., Totsuka M., Takato R., Hachimura S., Sato T., Ametani A., Kumagai Y., Habu S., Kaminogawa S. Primary response of naïve CD4+ T cells to amino acid-substituted analogs of an antigenic peptide can show distinct activation patterns Th1- and Th2-type cytokine secretion, and helper activity for antibody production without apparent cytokine secretion. FEBS Lett. 2000, 465:28-33.
19. Ise W., Totsuka M., Sogawa Y., Ametani A., Hachimura S., Sato T., Kumagai Y., Habu S., Kaminogawa S. Naive CD4+ T cells exhibit distinct expression patterns of cytokines and cell surface molecules on their primary responses to varying doses of antigen. J. Immunol. 2002, 168:3242-3250.
20. Kim P.J., Pai S.Y., Brigl M., Besra G.S., Gumperz J., Ho I.C. GATA-3 regulates the development and function of invariant NKT cells. J. Immunol. 2006, 177:6650-6659.
21. Kronenberg M., Gapin L. The unconventional lifestyle of NKT cells. Nat. Rev. Immunol. 2002, 2:557-568.
22. Makowska A., Kawano T., Taniguchi M., Cardell S. Differences in the ligand specificity between CD1d-restricted T cells with limited and diverse T-cell receptor repertoire. Scand. J. Immunol. 2000, 52:71-79.
23. Martin S.F., Esser P.R., Weber F.C., Jakob T., Freudenberg M.A., Schmidt M., Gokeler M. Mechanisms of chemical-induced innate immunity in allergic contact dermatitis. Allergy 2011, 66:1152-1163.
24. Mendiratta S.K., Martin W.D., Hong S., Boesteanu A., Joyce S., Van Kaer L. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity 1997, 6:469-477.
25. Niiyama S., Tamauchi H., Amoh Y., Terashima M., Matsumura Y., Kanoh M., Habu S., Komotori J., Katsuoka K. Th2 immune response plays a critical role in the development of nickel-induced allergic contact dermatitis. Int. Arch. Allergy. Immunol. 2010, 53:303-314.
26. Oblak A., Pohar J., Jerala R. MD-2 determinants of nickel and cobalt-mediated activation of human TLR4. PLoS One. 2015, 10(3):e0120583. 10.1371/journal.
27. Parekh V.V., Wilson M.T., Olivares-Villagómez D., Singh A.K., Wu L., Wang C.R., Joyce S., Van Kaer L. Glycolipid antigen induces long-term natural killer T cell anergy in mice. J. Clin. Invest. 2005, 115:2572-2583.
28. Potnis P.A., Dutta D.K., Wood S.C. Toll-like receptor 4 signaling pathway mediates proinflammatory immune response to cobalt-alloy particles. Cell. Immunol. 2013, 82:53-65.
29. Raghavan B., Martin S.F., Esser P.R., Goebeler M., Schmidt M. Metal allergens nickel and cobalt facilitate TLR4 homodimerization independently of MD2. EMBO Rep. 2012, 13:1109-1115.
30. Satoh M., Andoh Y., Clingan C.S., Ogura H., Fujii S., Eshima K., Nakayama T., Taniguchi M., Hirata N., Ishimori N., Tsutsui H., Onoé K., Iwabuchi K. Type II NKT cells stimulate diet-induced obesity by mediating adipose tissue inflammation, steatohepatitis and insulin resistance. PLoS One 2012, 7:e30568. 10.1371/journal.pone.0030568.
31. Schmidt M., Raghavan B., Müller V., Vogl T., Fejer G., Tchaptchet S., Keck S., Kalis C., Nielsen P.J., Galanos C., Roth J., Skerra A., Martin S.F., Freudenberg M.A., Goebeler M. Crucial role for human Toll-like receptor 4 in the development of contact allergy to nickel. Nat. Immunol. 2010, 11:814-819.
32. Skold M., Rytter A., Ivars F., Cardell S. Characterization of sub-populations of T-cell receptor intermediate (TCRint) T cells. Scand. J. Immunol. 1999, 49:611-619.
33. Smiley S.T., Kaplan M.H., Grusby M.J. Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells. Science 1997, 275:977-979.
34. Stetson D.B., Mohrs M., Reinhardt R.L., Baron J.L., Wang Z.E., Gapin L., Kronenberg M., Locksley R.M. Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function. J. Exp. Med. 2003, 198:1069-1076.
35. Tamauchi H., Terashima M., Ito M., Maruyama H., Ikewaki N., Inoue M., Gao X., Hozumi K., Habu S. Evidence of GATA-3-dependent Th2 commitment during the in vivo immune response. Int. Immunol. 2004, 16:179-187.
36. Wang Z.Y., Kusam S., Munugalavadla V., Kapur R., Brutkiewicz R.R., Dent A.L. Regulation of Th2 cytokine expression in NKT cells: unconventional use of Stat6, GATA-3, and NFAT2. J. Immunol. 2006, 176:880-888.
37. Wilson M.T., Johansson C., Olivares-Villagómez D., Singh A.K., Stanic A.K., Wang C.R., Joyce S., Wick M.J., Van Kaer L. The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:10908-10913.
38. Yoshimoto T., Paul W.E. CD4pos: NK1. 1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J. Exp. Med. 1994, 179:1285-1295.